New drug trial offers hope for untreatable seizure disorders
Disease control
Not yet recruiting
This early-stage study is testing whether an oral drug called SVG103 is safe and tolerable for adults with three rare brain conditions that cause severe, hard-to-control seizures. About 15 participants will take the drug for up to 9 months while researchers monitor for side effec…
Phase: PHASE1, PHASE2 • Sponsor: Sovargen • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC